Table 3 Characteristics of myocardial lesions on 68Ga-DOTATATE PET in NET patients
Patients (n = 15) with myocardial lesions (n = 21) | |
|---|---|
Myocardial lesion at baseline | 5 (45%) |
Time from initial diagnosis to lesion appearance (yrs) | 6 (2–10) |
Patients with multiple lesions | 3 (20%) |
Patients with pericardial effusion | 0 (0%) |
Location | |
Left atrial | 0 (0%) |
Left ventricular | 9 (43%) |
Septal | 9 (43%) |
Right atrial | 0 (0%) |
Right ventricular | 3 (14%) |
Lesion SUVmax | 8.6 (5.2–17.4) |
Lesion SUVmean | 4.3 (3.7–11.6) |
Spleen SUVmax | 22.3 (16.4–27.2) |
Spleen SUVmean | 19.1 (14.7–25.8) |
Lesion appearance on CT imaginga | |
hyper−/ iso−/ hypodense | 0 / 3 / 1 |
Lesion appearance on liver MR imaginga | |
T2w-hyper- / iso- / hypointense | 5 / 0 / 0 |
T1w-hyper- / iso- / hypointense | 0 / 3 / 0 |
CE-T1w-hyper- / iso- / hypointense | 0 / 4 / 0 |